ACI logo

Archean Chemical Industries Limited IPO

ListedMainboard
Price band
₹386 – ₹407
Open – close
09 Nov 2022
to 11 Nov 2022
Listing
21 Nov 2022

What the filing actually says

Our read of the offer document and the exchange data — not the issuer's summary of itself

We can't judge this issue yet. A verdict needs at least three independent dimensions — valuation, growth, profitability, balance sheet, issue structure, governance or demand — and this issue does not yet publish enough of them for a read that would mean anything. No offer document for this issue has been published yet. A confident score from two fields would be worse than this notice.

Dates

The issuer's tentative timetable — a date passing is not confirmation the step completed

  1. Opens
    09 Nov 2022
  2. Closes
    11 Nov 2022
  3. Listing
    21 Nov 2022

The offering

Terms, structure and who is selling

Terms
Price band₹386 – ₹407
Listing atMainboard
Company & valuation
ISININE128X01021

What happened to comparable issues

The last 8 issues to list with a recorded opening price, most comparable first

Median listing gain
+6.7%
Listed up
6 of 8
Best
+47.2%
SS Retail Limited
Worst
-2.4%
Hero Motors Limited
NSEsame segment
5.7× sub+0.8%
2.0× sub+3.3%
177.0× sub+29.0%
SS Retail Limitedsame segment
107.4× sub+47.2%
7.0× sub-2.4%
29.5× sub+0.0%
14.6× sub+10.0%
66.0× sub+26.0%

Past issues are context, not a forecast — this issue is a different company at a different price. We show it because "how have issues like this one actually opened" is a question with a real answer, and grey-market premium is not that answer.

Disclaimer. Figures are compiled from the issuer's offer document and exchange-published bidding data. Subscription changes until the issue closes, and the final basis of allotment is published by the registrar. Grey-market premium is unofficial and is not a forecast. Nothing here is investment advice or a recommendation — read the offer document and consult a SEBI-registered adviser before applying.

Archean Chemical Industries Limited IPO — GMP, subscription & review | DocStoX